Figure 1.
Behavioural evaluation of TIV-treated CUMS mice and controls. (A) Changes in body weight. (B) Immobility time in TST for CUMS mice with TIV treatment. (C) Sucrose preference in SPT for CUMS mice with TIV treatment. Data are reported as mean ± SD. # p < 0.05 and ## p < 0.01 vs. the normal group. *p < 0.05 and **p < 0.01 vs. the model group. N: normal; M: model; S: fluoxetine; L: TIV-L; Me: TIV-M; H: TIV-H.